Corporate Banner
Satellite Banner
Stem Cells, Cellular Therapy & Biobanking
Scientific Community
Become a Member | Sign in
Home>News>This Article

Intelsius Introduces Revised PharmaTherm™ Solutions

Published: Wednesday, January 29, 2014
Last Updated: Wednesday, January 29, 2014
Bookmark and Share
Company introduces PharmaTherm™ solutions at the 13th Annual Cool Chain Europe Summit in Luxembourg.

Intelsius has introduced revisions to its PharmaTherm™ line of solutions to pharmaceutical industry professionals at the 13th Annual Cool Chain Europe Summit in Luxembourg.

“Intelsius is refining one of our best-selling product lines to stay ahead of the constantly changing pharmaceutical industry,” said David Walsh, CEO, Intelsius. “All three new sizes provide optimal thermal protection for pharmaceutical products.”

PharmaTherm R solutions are regulatory compliant to meet the qualifications in the new GDP Guidelines for the EU that expanded and became more uniformly regulated in September 2013.

PharmaTherm R solutions are pre-qualified to the Intelsius High Performance profile and maintain payload integrity during shipments for 72 hours. The three sizes available utilize the same size coolant across the range and have a universal pack out making them easy to assemble, operationally friendly, tamper-evident and economical to ship.

“These additions allow more flexibility in payload sizes making them an Intelsius innovation,” said Steve Healy, Intelsius global director of sales. With interchangeable components and common features across the range, suitable solutions are available for all temperature controlled shipping requirements. The PharmaTherm family now offers pre-qualified 72 hour 2-8 degrees C, 96 hour 15-25 degrees C, PCM and dry ice solutions.

“The revised PharmaTherm line of products will help our customers save on storage space and shipping costs,” said Walsh. “As we continue to protect life’s most precious cargo we create innovative products that provide intelligent solutions.”

PharmaTherm products maintain appropriate temperatures and keep products safe while being transported. In addition, its discreet design keeps the contents confidential.

Intelsius serves a wide range of organizations including government agencies, leading pharmaceutical, biopharmaceutical and clinical research industries to major laboratories. Intelsius is the preferred response partner for human and veterinary epidemic and pandemic events in the UK and the Republic of Ireland.

Further Information
Access to this exclusive content is for Technology Networks Premium members only.

Join Technology Networks Premium for free access to:

  • Exclusive articles
  • Presentations from international conferences
  • Over 2,800+ scientific posters on ePosters
  • More than 4,000+ scientific videos on LabTube
  • 35 community eNewsletters

Sign In

Forgotten your details? Click Here
If you are not a member you can join here

*Please note: By logging into you agree to accept the use of cookies. To find out more about the cookies we use and how to delete them, see our privacy policy.

Scientific News
Shining Light on Microbial Growth and Death Inside our Guts
Precise measurement of microbial populations in gastrointestinal tracts could be key to identifying novel therapies.
How a Genetic Locus Protects Adult Blood-Forming Stem Cells
Mammalian imprinted Gtl2 protects adult hematopoietic stem cells by restricting metabolic activity in the cells' mitochondria.
Fat Cells Originating from Bone Marrow Found in Humans
Cells could contribute to diabetes, heart disease.
Ancient Viral Molecules Essential for Human Development
Genetic material from ancient viral infections is critical to human development, according to researchers at the Stanford University School of Medicine.
CRI Identifies Emergency Blood-formation Response
Researchers report that when tissue damage occurs, an emergency blood-formation system activates.
New Way to Force Stem Cells to Become Bone Cells
Potential therapies based on this discovery could help people heal bone injuries or set hardware, such as replacement knees and hips.
Dead Bacteria to Kill Colorectal Cancer
Scientists from Nanyang Technological University (NTU Singapore) have successfully used dead bacteria to kill colorectal cancer cells.
Promise of Newborn Stem Cells to Revolutionize Clinical Practice
In this article Shweta Sharma, PhD, discusses the potential of an Umbilical Cord Blood bank as an untapped source of samples for research and clinical trials.
The Life Story of Stem Cells
A model analyses the development of stem cell numbers in the human body.
Novel Stem Cell Line Avoids Risk of Introducing Transplanted Tumors
Progenitor cells might eventually be used to repair or rebuild damaged or destroyed organs.
Skyscraper Banner

SELECTBIO Market Reports
Go to LabTube
Go to eposters
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,800+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,000+ scientific videos